PF-Atlas › Clinical Trials › NCT04279197
Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu
Fuzheng Huayu Tablet · Phase 2
Registry ID
NCT04279197
Phase
Phase 2
Status
Completed
Drug / intervention
Fuzheng Huayu Tablet
Sponsor
ShuGuang Hospital
Start
2020-04-23
About this trial
Fuzheng Huayu Tablet is evaluated in NCT04279197, a Phase 2 idiopathic pulmonary fibrosis study sponsored by ShuGuang Hospital. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04279197 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.